News | November 29, 2023
Aster to separate its India and GCC businesses to unlock value
Both the India and GCC entities will be operated by separate dedicated management teams
Both the India and GCC entities will be operated by separate dedicated management teams
Likmez oral suspension is the first and only FDA-approved liquid option for patients with adherence hurdles such as dysphagia, difficulty swallowing
Phase 3 data expected in the second half of 2024
The company reported net profit after share of profit/loss of JV and minority interest at Rs. 752 crore vs. Rs. 409 crore in Q2FY23
Zydus will pay an upfront consideration of GBP 68 million and yearly earn-outs until 2026
NATCO's Pharmacovigilance Department was inspected from October 30, 2023 to November 1, 2023
The inspection of the facility conducted from August 7 to August 11, 2023
Dozee Pro Ex will offer Ambulatory patient monitoring for a seamless continuum of patient monitoring across different care settings
This integrated care offering is a step forward in our vision of providing an effective continuum of care for patients
The U.S. FDA has determined that the inspection classification of the facility is Voluntary Action Indicated
Subscribe To Our Newsletter & Stay Updated
